A B S T R A C T We have investigated whether changes in cellular fatty acid saturation can influence prostacyclin (PGI2) production by cultured human umbilical vein endothelial cells. As compared to control cells, those enriched with linoleic acid released 60-75% less PGI2 in response to thrombin or the calcium ionophore A23187. A similar but considerably smaller effect was observed when the cells were enriched with oleic or linolenic acid, but no reduction occurred with palmitic or linoelaidic acids. Some reduction in PGI2 release was noted as early as 1 h after exposure to linoleic acid. When the culture medium was supplemented with linoleic acid, the cell phospholipids contained four to five times more linoleate and 25-40% less arachidonate. These changes were most marked in the choline and serine plus inositol phosphoglyceride fractions. When the fatty acid composition of the cells enriched with linoleic acid was allowed to revert, there was a progressive increase in the capacity ofthe cells to release PGI2 in response to thrombin. The increase correlated with a reduction in linoleate content of the cell lipids, but there was no change in arachidonate content. This suggests that linoleic acid may act as an inhibitor of PGI2 production. The cultured endothelial cells were also able to produce PGI2 directly from added arachidonic acid. As the arachidonic acid concentration of the medium was raised, PGI2 formation by the linoleate-enriched cells increased relative to control cells, suggesting that the inhibition produced by INTRODUCTION Prostacyclin (PGI2)' is a prostaglandin that acts as a vasodilator and an inhibitor of platelet aggregation (1, 2) . PGI2 is produced by a number oftissues, including 6-keto-PGF,, the number 6-keto-derivative ofprostaglandin F,.
blood vessel preparations (3) (4) (5) (6) . Endothelial cells in culture also synthesize PGI2 (7) , and either arachidonic acid or prostaglandin endoperoxide H2 can serve as the substrate (8) . PGI2 production by the endothelial cell is stimulated by thrombin, trypsin, or the calcium ionophore A23187 and is inhibited by acetylsalicylic acid (9) (10) (11) (12) . Because PGI2 probably is involved in the prevention of thrombosis, it is important to investigate the factors that regulate its production by the endothelium.
Human endothelial cells readily use free fatty acid, and much of the uptake is incorporated into cellular phosphoglycerides and acylglycerols (13) . When endothelial cell monolayers are fed arachidonic acid, their inhibitory effect on platelet aggregation is enhanced (14) , probably because PGI2 production is stimulated (8) . An enhancement of the antiaggregating effect was not observed, however, when the cells were fed linoleic acid (14) . This is unexpected, for linoleic acid serves as a precursor for arachidonic acid synthesis. Certain tumor cells cannot convert linoleate to arachidonate, but cultured human diploid cells are reported to contain this elongation and desaturation pathway (15, 16 (17) , and primary cultures were prel)ared according to a slight modification of' the mnethod of Jaffe et al. (18) . The cells were suspended in a modified mlediu ili 199 containiing 20% fetal calf' seruiml (17) , seeded in 35 x 10-mmlln tissue cultuire dishes, atnid incuhated in a 5% C(2 atmoiiphere at 37C. After 24 h, this meditiumi was replaced wvith 2 ml of medium 199 containing 25 (6-keto-PGFi), bv at radioimmunoassav (12) In ainother series of experiments, the abilitx of the cells to form PGI2 directly from arachidonie ateid wais issessed (8 (21) . Gats-liqutid chromatography was mise (l to analzye the fatty acid comipositioni of the lipid extract (22) .
Phospholiplids and neuitral lipids were separated 1w tlinslayer chromatography on .silica gel G plates. The chromiiatogramiis were developed in a solvent system of hexane-diethl\ ether-acetic:acid-methanol (170:40:4:4). After eluition fromii the silica gel with chloroformii-methalnlol 1: 1 (vol/vol), the phospholipid and neuitral lipid fractions wvere saponified, and the fatty acids wvere extracted in hexane. After methylation (23 (8) . After staining with 12 vapor and siublimationi, the radioactivity contained in the otitlinied segmiienits of silica gel was measured in a liquid scintillationi spectronleter.
In the empty dish controls, an average of only 0.45% of the added arachidoniic aicid radioactivity miigrated in the regioni of the 6-keto-PGF1, standard. This smiiall amouniit of l)ackground radioactivity was subtracted from the quantity retovere(l in the 6-keto-PGF1, region of the chromncatogramlls fromll the incubations xvith enidothelial cell monolavers.
RESULTS
Composition ofendothelial cell lipids. WVhen either oleic or linoleic acid was added to the ecultture miiedliuml, the fatty acid composition of the endothelial cell lipids w,as modified appreciably. This is illuistr-atte(d by the data showni in Table I (8) . This procedure was employed to determine whether fatty acid enrichment also would influence the ability of the cells to produce PGI2 when arachidonic acid was available in the assay nmedium. In the initial experiments with control cells, we compared PGI2 production measured by the radioimmunoassay to that measured in duplicate incubations containing [1-'4C] arachidonic acid by thin-layer chromatography (8) . It was assumed in calculating the thin-layer chromatography results that there was no dilution of the added [1-14C]arachidonic acid by endogenous unlabeled substrate. The PGI2 production as measured by the radioimmunoassay was 408±46 pmol/ml, whereas the value obtained by thin-layer chromatography was 572±76 pmol/ml (n = 5). These results are interpreted to indicate that essentially all of the PGI2 produced in this assay is derived directly from the arachidonic acid added to the meditum.
With the radioimmtunoassay procedure, we tested the ability of the cells enriched with fatty acid to produce PGI2 when the medium contained 20 ,uM arachidonic acid but no albumin. Release was considerably greater under these conditions than when the thrombin stimulus was employed. No significant differences in PGI2 release were observed, however, when the control cells were compared to those grown in the media supplemented with either oleic or linoleic acid.
Additional experiments were done to determine whether the availability of extracellular arachidonic acid would influence the capacity of the cells enriched with linoleic acid to produce PGI2. Each of the assay media contained 50 ,uM albumin and, as shown in Table IV , the arachidonic acid concentration was varied from 10 to 400 uN.l. As the arachidonic acid concentration was raised, the amount of PGI2 produced by both types of cells increased markedly. Moreover, relative to the control cells, progressively more PGI2 was produced by the cells enriched with linoleic acid as the arachidonic acid concentration was raised. For example, the cells enriched with linoleic acid released only 16% as much PGI2 as the control cells when 10 tuM arachidonic acid was present, whereas they released 92% as much when the arachidonic acid concentration was 400 uM. At the higher arachidonic acid concentrations, and the cells enriched with linoleic There was an effect on PGI2 production in response to thrombin as early as 1 h after the cells were exposed to the medium containing supplemental linoleic acid. As compared to the control cells, the cells incubated with linoleic acid for the 1 h released 40% less PGI2. By contrast, the effects of short-term exposure to oleic acid were quite variable, and no consistent difference as compared to the control cells was noted during the first 24 h.
Other fatty acids. In an attempt to determine whether the reductions in thrombin stimulated PGI2 release might be a nonspecific toxic effect, additional fatty acids were tested. As shown in Table V Fig. 1 . The culture media were supplemented with 150 j,uM ofthe fatty acid, and 0.5 U ofthrombin was added to elicit PGI2 release. Each value is the mean+SE of six separate cultures.
I P < 0.001. § P < 0.01.
n-3 series, produced only a 35% reduction. Therefore, of the fatty acids tested, only linoleic acid consistently produced a decrease in PGI2 release of 50% or greater in response to thrombin. The cell counts were not appreciably reduced when supplemental fatty acids were present in the culture medium. Linoelaidic acid, which produced the largest decrease in cell couint (16%), had essentially no effect on PGI2 release. Taken together, these findings indicate that a nonspecific toxic action is not the mechanism whereby supplemental linoleic acid inhibits the thrombin stimulated release of PGI2.
PGI2 release in response to a calcium ionophore. In addition to thrombin, the calcium ionophore A23187 stimulated PGI2 production, and differences in PGI2 release between the control cells and those grown in the fatty acid supplemented media were observed. The effects of exposure to the fatty acid supplemented media for 15 min to 72 h are shown in Table VI . The largest difference between the control and oleic acid supplemented cells at any ofthe times tested was -10%. There was a 13-27% decrease in PGI2 release from cells exposed to linoleic acid during the first 3 h and after 72 h of exposure, the linoleate-enriched cells produced from 50 to 75% less PGI2 than the control cells. These differences between the linoleate-enriched and the control cells are similar to those observed when PGI2 production was stimulated by thrombin, but the reductions in the oleate-enriched cells are Fig. 2 . When the medium was changed, the cell lipids were highly enriched in 18:2. During subsequent culture in the unsupplemented medium, the 18:2 content of the cell phospholipids and neutral lipids decreased progressively. There was no ap- 48 TIME (h) FIGURE 2 Prostacyclin release and fatty acid compositional changes during reversion of cells supplemented with linoleic acid. Cultured endothelial cells were exposed for an initial 24-h period to medium supplemented with 150 uM linoleic acid. This medium then was removed, and fresh medium containing no supplemental fatty acid was added. Three of the cultures were taken immediately for measurement of PGI2 release, and this set is shown as 0 h. Additional sets of three cultures were assayed for PGI2 release at 6, 24, 48, and 72 h after transfer to the unsupplemented medium. At each time, three control cultures treated in the same way except that they were exposed to an unsupplemented medium during the initial 24-h period also were assayed for PGI2 release. The stimulus for PGI2 release was 0. release occurred at early time points when the overall unsaturation of the membrane lipids was changed only slightly. The mechanism also is unlikely to involve the thrombin receptor, for the effect occurred when the calcium ionophore was used to by-pass the thrombin activation process. These exclusions suggest that the mechanism involves a direct effect of the change in cellular linoleic and arachidonic acid content.
The most likely possibility is that a prostaglandin biosynthetic enzyme, probably cyclooxygenase, is inhibited by the increase in intracellular linoleic acid. In sheep vesicular gland and rat stomach extracts, prostaglandin synthesis is inhibited when linoleic acid is added (25) . A similar inhibition occurs in microsomes prepared from human epidermis and platelets (26, 27 (Fig. 2) . In addition, the arachidonic acid assay indicates that the decrease in PGI2 production can be overcome as the availability of substrate is increased (Table IV) . This suggests that linoleic acid may be acting as a competitive inhibitor.
In such a mechanism, intracellular unesterified linoleic acid would be the actual inhibitor. Cells obtain unesterified fatty acid from either the surrounding medium or the hydrolysis of intracellular lipid esters (28) . Because the endothelial cells were washed with albumin after culture, most of the unesterified fatty acid taken up from the medium probably was removed (29) . Therefore, unesterified fatty acid contained in the cells at the time of the PGI2 assay must have been derived primlarily from intracellular lipid esters. Rapid and continuious release of fatty acid from intracellular phospholipid pools has been demonstrated in mammalian cells (30) . As a result of such turnover, the cell unesterified fatty acid pool would be expected to contain imore linoleic acid when the intracellular phospholipids are enriched in linoleate, thereby having a higher inhibitor concentration. An alternative but related mechanism is that inhibitory concentrations of linoleic acid may be released from phospholipids when the cells are stimulated by either thrombin or the calcium ionophore. In normal human platelets, however, thrombin specifically releases arachidonate, and the linoleic content of the intracellular free fatty acid pool does not increase in response to stimulation (31) . This selectivity argues against a specific release mechanism involving linoleic acid. Because it is not known whether the release in platelets would remain specific if they were enriched in linoleate, this possibility cannot be totally excluded.
Although our findings support an inhibitory role for linoleate, the associated decrease in the arachidonic acid content of the cell lipids also could be responsible for the lesser PGI2 release in response to external stimulation. The quantity of arachidonic acid in cell lipids has been shown to regulate prostaglandin production in mouse fibroblasts (32) . Likewise, reductions in tissue arachidonate content caused by feeding diets low in essential fatty acids lead to a decrease in prostaglandin production (33) . Infants who develop essential fatty acid deficiency during total parenteral nutrition also excrete less urinary prostaglandin metabolites (34) . Furthermore, the phospholipid fractions that exhibit the largest decrease in arachidonate, the choline phosphoglycerides and the fraction containing the inositol phosphoglycerides, provide the arachidonic acid for prostaglandin synthesis in human platelets (31, 35, 36) . Even if diglycerides actually are the direct source of the arachidonic acid, they appear to be derived in the platelet from inositol phosphoglycerides (36, 37) . Although a mechanismn involving a lesser availability of arachidonic acid in cellular lipids is consistent with many of our findings, it cannot explain the reduced PGI2 production whien low concentrations of arachidonate are added to the assay (Table IV) . Under these conditions, most of the PGI2 is derived from the added arachidonic acid, and the intracellular arachidonate content should not appreciably affect the amiiount of available substrate. Therefore, if the mechlanism involves the reduced arachidonate content of the cellular phospholipids, one or more additional factors must be invoked to explain this finding as well as the results of the reversion studies.
Inasmuch as arachidonic acid is formed from linoleic acid, it is surprising that enrichment with linoleate causes a reduction in the arachidonate content of the cell phospholipids. This finding, however, is not peculiar to endothelial cells. Human skin fibroblasts contain 58% less arachidonate in phospholipids when they are enriched with linoleate in culture (22) . Likewise, enrichment of mouse peritoneal macrophages with linoleate leads to a 55% reduction in arachidonate content (38) . On the other hand, the arachiidonate content increases in mouse astroblasts when they are enriched with linoleate (39) , indicating that the effect is not generalized.
The finding that linoleate enrichment is associated with reduced PGI2 release is potentially important clinically. Linoleic acid is the predominant polyenoic fatty acid in many of the currently used diets that are high in polyunsaturated fat, such as those containing corn, safflower, or sunflower seed oil. When these diets are consumed for 1-2 wk, there is a large increase in the percentage of linoleic acid in the plasma lipoproteins (40) (41) (42) . Moreover, the chylomicron triglycerides and the plasma free fatty acids become highly enriched with linoleic acid within 4-6 h after a single meal containing corn oil or safflower oil (43) (44) (45) (46) , and they remain enriched with linoleic acid for 35-47 h after such a meal (40) . In the plasma free fatty acid fraction, linoleic acid accounts for 40-50% of the fatty acids after ingestion of safflower oil, whereas it accounts for only 15% of the plasma free fatty acids in the fasting state (46) . By contrast, a decrease in the percentage as well as the total amount of arachidonate in the plasma free fatty acid fraction occurred when safflower oil was fed (46) . Therefore, it appears that the plasma bathing the endothelium is highly enriched in linoleic acid but not in arachidonic acid when large quantities of the commonly available polyunsaturated fats are ingested. These results suggest that the endothelium may accumulate linoleic acid under these conditions and that this may reduce its capacity to release PGI2. Inasmuch as PGI2 inhibits platelet aggregation (1, 2) , it is possible that the protective capacity of the endothelium against thrombosis may be reduced when increased quantities of polyunsaturated fats are consumed.
